Pain Relief Medication Market – A market with high CAGR and return on investment by 2025

 Market Highlights

According to MRFR analysis, Pain Relief Medication Market  is expected to register a CAGR of 4.73% during the forecast period of 2019 to 2025 and held a value of USD 55,275 million in 2018.

Pain relief medicine is a branch of medicine that employs an interdisciplinary approach for easing the suffering and improving the quality of life of those living with acute as well as chronic pain.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8431

The growth of the global pain relief medication market is driven by several factors such as increasing patient population suffering from chronic pain and cancer pain, increasing research in the pain management field, and rising product launch in the pain relief medication market. However, the stringent regulations and high cost of drugs are likely to hamper the growth of the global pain relief medication market.

Several market players currently dominate the global pain relief medication market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, in July 2018, AbbVie received approval for Orilissa (elagolix) from the US Food and Drug Administration (FDA) for the management of moderate to severe pain associated with endometriosis.

Segmentation

The global pain relief medication market has been segmented based on drug class, indication, and distribution channel.

The market, based on drug class, has been divided into nonsteroidal anti-inflammatory drugs, opioids, COX-2 inhibitors, and others. The nonsteroidal anti-inflammatory drug segment is likely to be the largest during the review period due to the high efficacy rate of this drug class. The opioids segment is predicted to be the fastest-growing due to the increasing awareness about the drugs in this class in the pain relief medication market.

The global pain relief medication market has been segmented based on the indication, into cancer pain, neuropathic pain, musculoskeletal pain, inflammatory conditions, and others. The cancer pain segment is expected to hold the majority share of the market owing to the increasing people suffering from this type of pain. The neuropathic pain segment is expected to be the fastest-growing due to the rising patient population in different economies.

The global pain relief medication market, by distribution channel, has been divided into hospital and retail pharmacies, and online pharmacies. The hospitals and retail pharmacies segment is projected to hold the largest share of the market due to the increasing number of hospital in-visits. The online pharmacies segment is expected to be the fastest growing owing to the rise in the awareness about online distribution network.

Key Players

Some of the key players in the global pain relief medication market are AbbVie Inc. (US), Allergan plc (Ireland), Astellas Pharma Inc. (Japan), Bayer (Germany), Biogen Idec (US), Boehringer Ingelheim International GmbH (Germany), Bristol-Myers Squibb (US), Eli Lilly and Company (US), GlaxoSmithKline (UK), Mallinckrodt Pharmaceuticals (UK), Pfizer, Inc. (US), Purdue Pharma (US), Sanofi (France), and Teva Pharmaceutical Industries Ltd (Israel).

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to be the largest market owing to the rise in chronic diseases in this region. In Brazil, chronic pain is a widespread clinical condition, affecting between 28% and 41% of the Brazilian population. The pain relief medication market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European pain relief medication market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The pain relief medication market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rise in initiatives by public and private organizations, the market in Asia-Pacific is expected to be the fastest-growing. The pain relief medication market in the Middle East & Africa has been divided into the Middle East and Africa.

FOR MORE DETAILS – @ https://www.marketresearchfuture.com/reports/pain-relief-medication-market-8431 

 

Perfusion Radiology Market Poised to Witness a Significant Growth by 2025

 Market Highlights

The Global Perfusion Radiology Market is expected to register a CAGR of 7.48% during the forecast period, with a market value of USD 9,858 Million till 2025. Perfusion is the passage of fluid through the lymphatic system to organs or tissues. Perfusion radiology is the process by which passage of perfusion can be observed, recorded, and quantified. This is widely used for the diagnosis of chronic disorders such as cancer, brain tumor, and lung-related disorders.

The growing prevalence of cardiovascular and neurological diseases, increasing geriatric population, and advancements in technology are expected to enhance market growth. However, the stringent regulatory policies and lack of awareness for the use of advanced technologies are projected to curb the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8419

Segment Analysis

The Global Perfusion Radiology Market, by application, has been segmented into cardiovascular imaging, ventilation imaging, brain imaging, and others. By end-user, the global perfusion radiology market has been classified as hospitals, diagnostic centers, and others. 

Regional Analysis

The Global Perfusion Radiology Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

North America accounted for the largest market share of in 2018, owing to the incidence of cardiovascular diseases, brain tumors, and tumor-related angiogenesis

Europe is anticipated to account for the second-largest market share during the forecast period. The market growth in Europe can be attributed to the considerable rise in neurological disorders. For instance, according to the European Brain Council, 2017 data, a total of 220.7 million people in Europe were suffering from at least one neurological disease, which promoted the use of perfusion radiology for the diagnosis of such diseases.

Asia-Pacific is likely to be the fastest-growing region in the global perfusion radiology market. The high growth rate is due to owing to the presence of rapidly developing economies of China, India, and South Korea. India held a share of 18.8% in the Asia-Pacific perfusion radiology market in 2018.

The Middle East & Africa market is projected to show gradual growth during the forecast period. In this region, the Middle East is anticipated to dominate owing to the presence of developed countries such as Egypt, Saudi Arabia, and others.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Perfusion Radiology Market— GE Healthcare (US), Siemens Healthineers AG (Germany), Canon Medical Systems Corporation (Japan), Bracco Diagnostic, Inc. (Italy), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Lantheus Medical Imaging, Inc (US), Perimed (US), Neusoft Corporation (China), and Advantis Medical Imaging (Netherlands)

Key Findings of the Study

• The Global Perfusion Radiology Market was valued at USD 6,009.3 million in 2018 and is estimated to grow to USD 9,858 Million by 2025 at a CAGR of 7.48% during the assessment period
• The Americas accounted for the largest share of the global market due to the increase in the incidence of cardiovascular diseases, brain tumors, and tumor-related angiogenesis.
• Based on application, the cardiovascular imaging segment accounted for a market share of 12% in 2018
• On the basis of the end-user, the hospital’s segment dominated the market and accounted for a share of 65% in 2018

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/perfusion-radiology-market-8419

 

Light Therapy Market to Witness an Outstanding Growth by 2025

 Light Therapy Market Overview: 

The global light therapy market is showing an opportunity for the market to achieve 5.1% CAGR during the forecast period of 2019 to 2025, with a valuation of USD 1,112.16 million. Market Research Future (MRFR) revealed several growth-inducing factors that can be studied to understand the market motions in the coming years. These factors are the rising dermatological disorders like acne vulgaris, Psoriasis, etc., which affect around 50 million US citizens per year, several psychological conditions like depression, rising investment in research and development, technological advancements, and inclusion of blue light therapies.  

However, side-effects like nausea and headache can create some limitations for the light therapy market. Lack of awareness can also prevent the market from achieving its normal growth.  

Get a FREE Sample (Including COVID19 Impact Analysis, Full TOC, Tables and Figures) of Light Therapy Market @ https://www.marketresearchfuture.com/sample_request/8366

Light Therapy Market Segmentation: 

MRFR analysts have segmented the global market for light therapy for a better review. This segmentation includes studies on product, application, light type, and end user. Figures and charts have backed fetched data from this segmentation.  

By product, the global market for light therapy has been segmented on the basis of the lightbox, floor & desk lamps, light visor, dawn simulator, light therapy bulbs, handheld devices for skin treatment (HDST), and others. The ‘others’ segment includes Bluewave technology and light on timer. The HDST segment is the largest in terms of revenue and market size.  

By application, the global market of light therapy covers Psoriasis, vitiligo, eczema, acne vulgaris, seasonal affective disorder (SAD), sleep disorders, and others. The ‘others’ segment covers bone injuries and joint pains. The sleeping disorder segment has the largest market share, whereas the Psoriasis segment is the fastest-growing one.  

By light type, the global light therapy market has been segmented into blue light, red light, white light, and others. The blue light segment has the largest market share and the red light is predicted to be the fastest-growing segment. 

By end user, the global market has been segmented into home care settings, dermatology clinics, and others. The ‘others’ segment includes workplace and salons. The homecare settings have the largest market coverage.  

Light Therapy Market Regional Analysis: 

North America would lead the global market from the front as the awareness regarding such therapies is high, and investment capacity for research works are also substantial. The US and Canada will take control of the global market.  

Competitive Landscape: 

The global market for light therapy is getting impacted by companies like Northern Light Technology (Canada), Chal-Tec GmbH (Germany), Lucimed SA (Belgium), Koninklijke Philips (Netherlands), Zepter International (Switzerland), Beurer (Germany), BioPhotas (US), Verilux (US), and Nature Bright (Taiwan), Lumie (UK).

Light Therapy Industry News: 

In May 2020, a research paper published in Scientific Reports claimed that bright light therapy is helping patients with Parkinson’s disease in improving their sleep. The disease affects the body clock significantly. The therapy helps in bringing a semblance in that and boost the sleeping pattern. The exact nature of impact is still a matter of discussion and also the reason behind the efficacy. However, researchers believe that it has several things to do with the circadian rhythm.  

In May 2020, the United States Food and Drug Administration (FDA) revealed that they had granted the designation of the breakthrough device to PhotoPharmics‘s light-based, at-home device that can work as an add-on therapy for Parkinson’s disease. This special status provides the company with a prioritized review of approval requests. The device is expected to boost the patient’s circadian rhythm to help maintain the sleep cycle and improve the metabolism rate. 

Obtain Premium Research Report Details @ https://www.marketresearchfuture.com/reports/light-therapy-market-8366

 

Future Growth of Spectral Computed Tomography Market is Expected to Grow Healthy CAGR till 2025

 Market Highlights

The GlobalSpectral Computed Tomography Market is expected to register a CAGR of 5.8% during the forecast period with a market value of USD 969.6 Million till 2025. Spectral computed tomography (CT) also known as dual-energy CT (DECT) is an advanced form of computed tomography widely used in x-ray scanning technique. Spectral computed tomography is an advanced medical imaging device, which helps in the differentiation and characterization of tissues through the high quality of X-ray images. Spectral computed tomography (CT) contains two different energy spectra to provide concise images on the basis of material density.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/1026 

The major key factors driving the market growth are increasing spending on the healthcare IT sector, technological advancements in the diagnostics sector, and increasing demand for diagnostic devices for precise imaging enhances the market growth. Also, the growing prevalence of cardiovascular and neurological diseases across the globe increase the demand for spectral computed tomography (CT) devices. However, factors such as high cost compared to conventional CT scan machines, availability of alternatives CT scan devices, and the less awareness about the products among the radiologists may hamper the market growth. 

Segment Analysis

The global spectral computed tomography market is segmented into application and end user. On the basis of application, the global spectral computed tomography market has been segmented into oncology, cardiology, musculoskeletal disorders, and gastrointestinal diseases. Based on end user, the market has been segmented into diagnostic centers and hospitals & clinics.

Regional Analysis

The global spectral computed tomography market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Asia-Pacific is expected to hold the largest share of the global spectral computed tomography market. This is owing to the increasing patient population suffering from cancer and cardiovascular diseases and growing geriatric population suffering from numerous diseases are boosting the market growth in this region.

The Americas market holds the second-largest position in the global spectral computed tomography market owing to the increasing healthcare expenditure, and the presence of large number of medical devices companies in this region.

Europe is the third-largest region in the global spectral CT market. Factors such as growth in the medical device industry, the presence of developed economies, high per capita disposable income, and increased healthcare spending by consumers are driving the growth of the market in this region.

The spectral computed tomography market in the Middle East & Africa accounts the least market share due to the adequate healthcare infrastructure support accounted for a relatively smaller market share in 2018.

Market Players

MRFR recognizes the following companies as the key players in the global spectral computed tomography market— General Electric Company (US), Koninklijke Philips N.V. (Amsterdam, Netherlands), MARS Bioimaging Ltd (Christchurch, New Zealand), Neusoft Corporation (China), Shenzhen Anke High-tech Co., Ltd (China), Siemens (UK), and PerkinElmer Inc. (Waltham, Massachusetts).

Key Findings of the Study

• The Global Spectral Computed Tomography Market was valued at USD 655.89 million in 2018, is estimated to grow at USD 969.6 million by 2025 at a CAGR of 5.8% during the assessment period
• Asia-Pacific accounted for the largest share of the global market due to the presence of key market players and an increasing patient population in Japan, China, and India.
• Based on application, the oncology segment accounted for the largest market share in 2018
• On the basis of the end user, the diagnostic centers dominated the market and accounted for a share of 3 million in 2018

FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/spectral-computed-tomography-market-1026 

 

EHR-EMR Market Poised to Witness a Significant Growth by 2023

 EHR-EMR Market Overview: 

The global EHR-EMR market has been predicted to surpass USD 42,427.27 million by 2027, with a CAGR of 5.82% during the forecast period of 2019 to 2027. Market Research Future (MRFR) claims that factors like the impact of COVID-19, better technological assistance, digitalization of several procedures, improvement in infrastructure, government initiatives, demand for simplifying access of patient records, and others are expected to ensure better growth for the market. EHR-EMR facilities have made the process of accessing health records simpler by issuing a single gateway.  

However, the initial price of installing such a process can deter market growth by some margin.  

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/819

COVID-19 Impact Analysis: 

The recent COVID-19 outbreak has inspired several changes in the treatment procedures. People have been asked to maintain social distance by various governments and this has lessened the number of people actually visiting a doctor or a hospital for treatment. In a way, it has spurred the inclusion of telemedicine. This is also a result of doctors trying to reduce contact possibilities. To make this process effective, hospitals are now ramping up their efforts of including EHR-EMR facilities as it will help in keeping track of their patients and their health records. Various healthcare IT providers are offering their assistance in building a proper setup to facilitate this shift. 

Given the debilitating Impact of COVID-19 (Coronavirus) on EHR-EMR Market, companies are on the lookout for starting production lines. Get an inside look at the market prospects and its future decisions in light of the pandemic and other such unforeseen circumstances.

EHR-EMR Market Segmentation: 

The global market for EHR-EMR has been segmented by MRFR analysts into component, application, mode of delivery, and end user. It relies heavily on data gleaned from these segments to provide better strategic opportunities to increase profit margin.  

By component, the global study containing details of the EHR-EMR market has been segmented into services & consulting software, and hardware. The software segment is showing the possibilities of evolving with the fastest speed during the forecast period. This plays a crucial role in making a proper assessment of the patient and his diagnostic time.  

By application, the global study centers around segments like specialty-based and general applications. The specialty-based segment has the chance to evolve as the fastest-growing segment during the forecast period. The specialty-based segment includes cardiology, radiology, oncology, neurology, and others. The cardiology segment was the leading one in 2016. 

By mode of delivery, the global report on the EHR-EMR market comprises on-premises and cloud-based. The on-premises segment covers almost 55% of the total market valuation. 

By end user, the global market discussion on the EHR-EMR market consists segments like hospitals & clinics, ambulatory care, and diagnostic centers. The hospitals & clinics segments are getting traction for their infrastructural scope and advantages regarding investment.  

EHR-EMR Market Regional Analysis: 

Better infrastructure, funding assistance, and increased digitalization would keep North America at the forefront. Countries like the US and Canada are going to contribute notably. In Europe, the market will gain prominence in countries like Germany, France, Italy, the UK, Russia, and others as their infrastructural advancement boosts market results.  

EHR-EMR Market Competitive Analysis: 

The global market for EHR-EMR is all set to benefit from the tactical improvements launched by companies like Cerner Corporation (US), GE Healthcare (US), Allscripts Healthcare Solutions (US), Athenahealth, Inc. (US), Advanced Data Systems Corporation (US), eClinicalWorks (US), AdvancedMD (US), and others. These companies are implementing changes of diverse sorts that span across mergers, collaborations, acquisitions, and others. It also includes various other methods like spurring the investment opportunities in the research sector, improving the chances of innovation, better launching, branding, and other marketing strategies. MRFR recorded all these latest moves to inspire a better study of the market that can impact the market outcome.  

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/ehr-emr-market-819

Global Solid Phase Extraction Market Expected to Grow with a healthy CAGR

 Solid Phase Extraction Market Analysis

As per Market Research Future (MRFR) analysis, the global solid phase extraction market is expected to reach USD 474.73 million with a CAGR of 4.62% from 2017 to 2023 (forecast period). The report on global solid phase extraction offers the in-depth primary research and a thorough analysis of qualitative and quantitative aspects by various industry analysts and key opinion leaders in order to provide valuable insight into market demand and industry performance.

Solid phase extraction (SPE) is a commonly used sample preparation process for purifying drugs from biological fluids prior to high-performance liquid chromatography. SPE is usually performed manually. In some instances, cost-effectiveness and disposability make manually operated SPE cartridges, disks, and plates preferable to automated systems.

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/7552

In recent years, technological developments in instrumentation, government investment in academics and life sciences, and expansion in the generic pharmaceutical industry and contract research organizations (CROs) have contributed to the development of the global demand for solid phase extraction industries. 

Solid Phase Extraction Market Dynamics

Solid phase extraction (SPE) is a sample preparation process by which compounds dissolved or suspended in a liquid mixture are isolated from other compounds in the mixture as per their physical and chemical properties. Growth in generics and CROs due to rising demand for drug production has contributed to a rise in the market for the solid phase extraction industry.

Government investments have increased over the last few years in the academic and life science sectors, which are the critical source of revenue for the solid phase extraction instrument manufacturers, and have also contributed to the development of the overall market.

However, the rising cost of instruments and government policies and regulations is likely to hinder market growth over the forecast period.

Solid Phase Extraction Market Segmentation

The global solid phase extraction market has been segmented into type and application.

Based on type, the global market for solid phase extraction has been divided into SPE disk and SPE cartridge. The segment for SPE cartridge is likely to register the highest CAGR of around 5.17% during the forecast period.

Based on application, the global market for solid phase extraction market is segmented into hospitals and clinics, pharmaceutical industries, and environmental care. 

Solid Phase Extraction Market Regional Analysis

Region-wise, the global solid phase extraction market is divided into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas are expected to dominate the market for the global solid phase extractive industry. It is due to the growing use of solid phase extraction in various industries, such as pharmaceuticals, biotechnology, agriculture, and others. The Americas is forecast to hold a 39.9% share in the global market for the solid phase extraction industry

Europe has shown considerable market growth as a result of the increase in biomedical and medical research in Europe.

The Asia Pacific is estimated to be the fastest-growing region on the market. The latest developments in instrumentation, changing economic conditions, growing innovation in biotechnology, and pharmaceutical research organizations in developing countries in the Asia Pacific are factors driving the growth of the global demand for solid phase extraction.

The Middle East and Africa has the lowest market share due to their low disposable income.

Solid Phase Extraction Market Key Players

The prominent participants in the global solid phase extraction industry market are Thermo Fisher Scientific Inc, PerkinElmer Inc, Gerstel GmbH & Co. KG, 3M, Gilson Incorporated, Merck KGaA, Agilent Technologies Inc., Biotage AB, Waters Corporation, GL Sciences Inc, and Tecan Trading AG.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/solid-phase-extraction-market-7552

 

Neonatal Intensive Care Market - Factors Driving Growth Post 2023

 

Market Highlights

It is estimated that the global neonatal intensive care market is expected to register a CAGR ~5.5% during the forecast period of 2018–2023 with an estimated market value of 9.1 billion in 2017.

The global market is driven by factors such as rising prevalence of diseases in new-born children and increasing neonatal population. According to data published by the Centers for Disease Control and Prevention in January 2017, there were 3,945,875 births in the US in 2017.

On the other hand, the lack of awareness, high cost of equipment, and lack of skilled professionals is restraining the growth of neonatal intensive care market. For instance, according to a report published by the International Journal of Neonatal Screening in September 2018, the reports of false positive cases in neonates are increasing for various diseases.

Browse Sample of the Report @   https://www.marketresearchfuture.com/sample_request/7513 

The global neonatal intensive care market is currently dominated by many market players. The key players in the market are involved in new product launches and strategic collaborations to strengthen its market position. For instance, PerkinElmer’s QSight 210 MD system launched in September 2016, utilizes tandem quadrupole analysis which provides regular robust screening along with higher sensitivity and faster scanning.

Regional Analysis

The market in the Americas is expected to dominate the global Neonatal Intensive Care market during the forecast period. The rising prevalence of congenital disorders in new-born, increasing neonatal population and government support are driving the growth of the market in the Americas. According to a data published by the Centers for Disease Control and Prevention (CDC) in November 2018, congenital heart defects (CHDs) affect approximately 1% or about 40,000 births per year in the US.

Europe showed a considerable amount of growth in the global neonatal intensive care market. The market growth in this region is because of the presence of a well-established healthcare system and increase in insurance coverage for pets. Also, technological advancements in the industry and government support in terms of National Health Service and health insurance are expected to drive the market growth.

Asia-Pacific is estimated to be the fastest growing region in the market due to increased pet adoptions and rise in the number of animal welfare programs.

On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. According to the American Society of Hematology (ASH), it led a campaign to fight sickle cell disease in Africa in June 2018. It also urged the governments, particularly in sub-Saharan Africa, to invest in new-born intensive care units for the betterment of the neonates.

Segmentation

The global neonatal intensive care market has been segmented into product, and end user. The market, based on product, has been segmented into infant warmers, incubators, respiratory devices, neonatal monitoring devices, convertible warmer & incubators, phototherapy equipment, catheters, and others. The market, by infant warmers, has been segmented into electric infant warmers, and non-electric infant warmers. The market, by neonatal monitoring devices, has been sub-segmented into cardiopulmonary monitor, blood pressure monitor, pulse oximeters, capnographs, and others. The market, by end user, has been segmented into hospitals, childcare clinics, and others.

Key Players

Some of the key players in the global neonatal intensive care market are B. Braun Melsungen AG, DRE Medical, Digicare Biomedical Technology Inc., Henry Schein, Jorgensen Labs, Medtronic, Midmark Corporation, Patterson Companies, Inc., Smiths Group plc, and Vetland Medical Sales & Services.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/neonatal-intensive-care-market-7513